Excess Deaths Upon Cessation of Xanthine Oxidase Inhibitor Treatment-Data From the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial: Comment on the Article by Choi et al

被引:8
作者
Bubb, Michael R. [1 ,2 ]
机构
[1] Malcom Randall Dept Vet Affairs Med Ctr, Gainesville, FL 32608 USA
[2] Univ Florida, Coll Med, Gainesville, FL 32611 USA
关键词
DISCONTINUATION;
D O I
10.1002/art.40914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1391 / 1392
页数:2
相关论文
共 5 条
[1]   Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review [J].
Beslon, Virginie ;
Moreau, Perrine ;
Maruani, Annabel ;
Maisonneuve, Hubert ;
Giraudeau, Bruno ;
Fournier, Jean-Pascal .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (03) :358-366
[2]   Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert [J].
Choi, Hyon ;
Neogi, Tuhina ;
Stamp, Lisa ;
Dalbeth, Nicola ;
Terkeltaub, Robert .
ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) :1702-1709
[3]   Drug Discontinuation Effects Are Part of the Pharmacology of a Drug [J].
Reidenberg, Marcus M. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02) :324-328
[4]   Medication adherence among patients with gout: A systematic review and meta-analysis [J].
Scheepers, Lieke E. J. M. ;
van Onna, Marloes ;
Stehouwer, Coen D. A. ;
Singh, Jasvinder A. ;
Arts, Ilja C. W. ;
Boonen, Annelies .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 47 (05) :689-702
[5]   Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout [J].
White, William B. ;
Saag, Kenneth G. ;
Becker, Michael A. ;
Borer, Jeffrey S. ;
Gorelick, Philip B. ;
Whelton, Andrew ;
Hunt, Barbara ;
Castillo, Majin ;
Gunawardhana, Lhanoo .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1200-1210